CNS PharmaceuticalsCNSP
13F holders, Q2 2025 (June 30)1holders
$0.85avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding CNS Pharmaceuticals Inc. (CNSP) in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($11).
- Company
- CNS Pharmaceuticals Inc.
- CUSIP
- 18978H508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11 |
| Exits | 0 | $0 |
Ownership 1 holders
| SBI Securities Co., Ltd. | 0.00% | New | 13 | $11 |
"% of holder's portfolio" is CNSP's weight in each manager's 13F, not the share of CNS Pharmaceuticals Inc. the manager owns.